The Board remands the claim for service connection for residuals of breast cancer due to deficiencies in an August 2023 VA opinion and to obtain a new TERA memorandum.
The deciding factor: Deficiencies in the August 2023 VA opinion require additional development, including obtaining a revised TERA memorandum and an addendum etiology opinion.
- Claimed conditions
- residuals of breast cancer
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- January 24, 2024
- Citation
- 24003596
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.